Natural Product: NPC145149

Natural Product IDNPC145149
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Purealdin L
IUPAC Name (5S,6R)-7,9-dibromo-N-[4-(diaminomethylideneamino)butyl]-6-hydroxy-8-methoxy-1-oxa-2-azaspiro[4.5]deca-2,7,9-triene-3-carboxamide
Synonyms Purealdin L
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL550970
PubChem CID 10391052
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0002490] Azolines
        • [CHEMONTID:0002211] Isoxazolines

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey VJEGSWJGTALRBW-SWLSCSKDSA-N
Standard InCHI InChI=1S/C15H21Br2N5O4/c1-25-11-8(16)6-15(12(23)10(11)17)7-9(22-26-15)13(24)20-4-2-3-5-21-14(18)19/h6,12,23H,2-5,7H2,1H3,(H,20,24)(H4,18,19,21)/t12-,15+/m0/s1
SMILES COC1=C(Br)[C@@H]([C@]2(C=C1Br)ON=C(C2)C(=O)NCCCCNC(=N)N)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   493.0 Volume:   366.413
?
Van der Waals volume.
Dense:   1.345 LogP:   0.074
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   0.607
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -1.756
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   9.0 Rigid Bonds:   13.0
TPSA:   142.05
?
Topological Polar Surface Area.
H-Bond Acceptor:   9.0
H-Bond Donor:   6.0 Rings:   2.0
Heavy Atoms:   11.0

MedChem Properties

QED Drug-Likeness Score:   0.201 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.531 Fsp3:   0.533
MCE-18:   52.174
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.562 Fluc inhibitor:   0.02
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.027
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.502
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.035 Promiscuous compounds:   0.028

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.77 MDCK Permeability:   -4.848
Pgp-inhibitor:   0.015 Pgp-substrate:   1.0
PAMPA:   0.884
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.42
20% Bioavailability (F20%):   0.885 30% Bioavailability (F30%):   0.998
50% Bioavailability (F50%):   0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.157 MRP1:   0.914
Plasma Protein Binding (PPB):   87.834% Volume Distribution (VD):   0.025
Fu: 9.829%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.985
OATP1B3 inhibitor:   0.994 BCRP inhibitor:   0.003
BSEP inhibitor:   0.004

ADMET: Metabolism

CYP1A2-inhibitor:   0.001 CYP1A2-substrate:   0.004
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.004
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.032
CYP2D6-inhibitor:   0.443 CYP2D6-substrate:   0.008
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.062
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.01
HLM stability:   0.079
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.341 Half-life (T1/2):  2.432

ADMET: Toxicity

hERG Blockers:  0.239 hERG Blockers (10um):  0.312
Human Hepatotoxicity (H-HT):  0.54 Drug-induced Liver Injury (DILI):  0.919
AMES Toxicity:  0.969 Rat Oral Acute Toxicity:  0.905
Maximum Recommended Daily Dose:  0.815 Skin Sensitization:  1.0
Carcinogencity:  0.95 Eye Corrosion:  0.0
Eye Irritation:  0.055 Respiratory Toxicity:  0.991
Drug-induced Neurotoxicity:  0.266 Ototoxicity:  0.589
Hematotoxicity:  0.023 Drug-induced Nephrotoxicity:  0.92
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.02
A549 Cytotoxicity:  0.026 Hek293 Cytotoxicity:  0.35
BCF:   0.79
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.584
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.215
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.404
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO29034 Suberea mollis Species Aplysinellidae Eukaryota n.a. red sea n.a. PMID[18656986]
NPO13261 Suberea clavata Species Aplysinellidae Eukaryota n.a. Australian n.a. PMID[19379003]
NPO29034 Suberea mollis Species Aplysinellidae Eukaryota n.a. Red Sea n.a. PMID[21542602]
NPO29034 Suberea mollis Species Aplysinellidae Eukaryota n.a. n.a. n.a. PMID[21542602]
NPO29034 Suberea mollis Species Aplysinellidae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO13261 Suberea clavata Species Aplysinellidae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO29034 Suberea mollis Species Aplysinellidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13261 Suberea clavata Species Aplysinellidae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT4197 Individual protein Coagulation factor XI Homo sapiens Inhibition = 12.0 % PMID[19379003]
NPT4655 Individual protein Coagulation factor IX Homo sapiens Inhibition < 5.0 % PMID[19379003]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus IZ = 5.0 mm PMID[21542602]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC145149 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9077 High Similarity NPC260270
0.7742 Intermediate Similarity NPC1702
0.75 Intermediate Similarity NPC158672
0.6912 Remote Similarity NPC487917
0.6667 Remote Similarity NPC473262
0.6667 Remote Similarity NPC202166
0.6486 Remote Similarity NPC473261
0.6486 Remote Similarity NPC300912
0.6286 Remote Similarity NPC45830
0.6234 Remote Similarity NPC470886
0.6154 Remote Similarity NPC66855
0.6076 Remote Similarity NPC130714
0.5974 Remote Similarity NPC313173
0.5955 Remote Similarity NPC607100
0.5873 Remote Similarity NPC30521
0.575 Remote Similarity NPC181086
0.5732 Remote Similarity NPC477220
0.5676 Remote Similarity NPC243106
0.5542 Remote Similarity NPC608121
0.55 Remote Similarity NPC81079
0.55 Remote Similarity NPC304257
0.5432 Remote Similarity NPC487872
0.5432 Remote Similarity NPC600759
0.5432 Remote Similarity NPC608122
0.5341 Remote Similarity NPC601097
0.5301 Remote Similarity NPC201900
0.5287 Remote Similarity NPC483876
0.5287 Remote Similarity NPC600925
0.5287 Remote Similarity NPC607066
0.5238 Remote Similarity NPC487873
0.5227 Remote Similarity NPC202866
0.5172 Remote Similarity NPC487915
0.5111 Remote Similarity NPC77435
0.5111 Remote Similarity NPC259071

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC145149 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data